The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.

bb1 by the numbers
More From The Market Online
Doctor at SNT

Existing myleofibrosis drugs can make the condition worse. Syntara Ltd could be about to change that 

In the face of a new war crisis weighing heavily on both equities and economics alike, value hunters (both long- and short-term minded

Dateline acquires its own rig for next planned Colosseum drilling

Dateline Resources has acquired its own rig to speed up drilling at the Colosseum gold and…

Expanding again: Haranga aiming to hit the ‘Mother Lode’ at Lincoln

Haranga Resources is set to release a resource upgrade at the Lincoln gold project in California…

Resource Minerals International extends Mpanda copper-gold target zone

Resource Minerals International has identified precious and critical metals potential at the Mpanda project in Tanzania.